Immunotherapy with GcMAF revisited - A critical overview of the research of Nobuto Yamamoto

Immunotherapy with GcMAF revisited - A critical overview of the research of Nobuto Yamamoto

This overview describes the research of Nobutu Yamamoto (Philadelphia) concerning immunotherapy with GcMAF for patients with cancer and for patients infected with pathogenic envelope viruses. GcMAF (Group-specific component Macrophage-Activating Factor) is a mammalian protein with an incredible pote...

Full description

Bibliographic Details
Main Author: Simon PJ Albracht
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Cancer Treatment and Research Communications
Subjects:
Nobuto Yamamoto (Philadelphia)
Immunotherapy
GcMAF
Nagalase
Cancer
Envelope viruses
Online Access:http://www.sciencedirect.com/science/article/pii/S2468294222000284

Internet

http://www.sciencedirect.com/science/article/pii/S2468294222000284

Similar Items